Published in
Elsevier, Radiotherapy & Oncology, 3(116), p. 358-365, 2015
DOI: 10.1016/j.radonc.2015.03.028
Links
Tools
Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells
Journal article published in 2015 by
Caroline V. M. Verhagen,
Rosemarie de Haan,
Floor Hageman,
Tim P. D. Oostendorp,
Annalisa L. E. Carli 
,
Mark J. O’Connor,
Jos Jonkers,
Marcel Verheij,
Michiel W. van den Brekel,
Conchita Vens
,
Mark J. O’Connor,
Jos Jonkers,
Marcel Verheij,
Michiel W. van den Brekel,
Conchita Vens
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 